Unraveling Integrin Antagonists' Target-Recognition Mechanisms  by Hantgan, Roy R. et al.
600a Wednesday, March 4, 2009conformational changes involved in the centrin-Sfi1p21 complex formation by
FT-IR spectroscopy, two dimensional correlation spectroscopy and isothermal
titration calorimetry. The binding was exothermic and the thermodynamic data
for Hcen1-Sfi1p21 was the following: N 1.335 0.0165, Ka 1.59 x10
75 2.48
x106 M, DH 1.72 x1045 301.1 kcal/mol and DS 23.8 kcal/mol. We have
also established the relative stability of these proteins by differential scanning
calorimetry. Our experiments address key questions underlying the molecular
basis of this complex interaction.
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Background: Pharmaceutical blockade of the platelet aIIbb3 integrin receptor
has reduced mortality from cardiovascular disease. However, gaps in mecha-
nistic understanding limit clinical efficacy and delay new drug development.
Objectives: Integrating surface plasmon resonance (SPR) and dynamic force
spectroscopy (DFS), we aim tomeasure the strength of integrin:ligand bonds, de-
termining their weakest link and identifying new therapeutic intervention routes.
Methods: cHarGD, a cyclic peptide structurally similar to eptifibatide, a widely
used antiplatelet drug, served as a model ligand, one readily coupled to biosen-
sors and AFM tips. SPR provided kinetic, equilibrium, and transition state ther-
modynamic parameters for aIIbb3:cHarGD complex formation, while DFS
measured their mechanical stability. cHarGA, lacking the aspartate required
aIIbb3 binding, served as a negative control.
Results: SPR demonstrated that integrin binding to immobilized cHarGD was
rapid (kon ~ 7  103 L/mol-sec at 25 oC), readily reversible (koff ~ 102 sec1),
and specific (100-fold smaller signals with cHarGA). Eyring and van’t Hoff
analyses indicated that after overcoming an entropic barrier (DGa
oz 12 kcal/
mol), both enthalpy and entropy favored assembly of the aIIbb3:cHarGD com-
plex (DG - 8 kcal/mol). Preliminary DFS experiments (12 nN/sec loading rate)
indicated that the rupture force of cHarGD:aIIbb3 is about 300 pN. In control
experiments, where the tip was functionalized with cHarGA or albumin, lower
rupture forces of 225 pN and 170 pN were observed.
Conclusions:Our SPR data indicate that entropy plays amajor role in target rec-
ognition by integrin antagonists, a property shared by ~25% of drug:receptor in-
teractions. Our DFS data suggest that integrin:ligand interactions are stabilized
by multivalent contacts between clustered receptors and pharmaceutical inhib-
itors.This studywill provide the first complete picture of the landscape for integ-
rin:ligand interactions, using temperature and force as thermodynamic variables
to determine the energetics and nm scale on which bond disruption occurs.
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Liver Fatty Acid Binding Protein (L-FABP), a small (14 kDa) abundant cytosolic
protein, may perform several functions in cells, including intracellular transport
of fatty acids, nuclear signaling, and regulation of intracellular lipolysis. Among
the members of the intracellular lipid binding protein (iLBP) family, L-FABP is
very unique in its ability to bind two molecules of FA and a variety of other bulky
ligands such as bilirubin. To help understand the promiscuous binding and trans-
port properties of L-FABP, we have applied multi-dimensional homonuclear and
heteronuclear NMR spectroscopy for studies of its structure and ligand binding.
The overall conformation of human L-FABP, as determined from NOE-derived
distance restraints, shows a b-clammotif comprised of a 10-stranded anti-parallel
b-sheet that is covered by 2 short nearly parallel a-helices. Ligand binding to L-
FABP is being studied by NMR titration experiments with two types of ligands.
In the case of oleic acid, which is the primary physiological ligand of L-FABP,
2D HSQC spectra with different binding stoichiometries showed two binding
sites with different affinities. In addition, two 13C-labeled bilirubin analogs
are being studied to assess binding of bulky ligands. We hypothesize that the
unique binding of bulky hydrophobic ligands enables the L-FABP to undergo
a conformational change that is different from the other FABPs.
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Splicing Factor 1 (SF1) and U2 snRNP auxiliary factor (U2AF65) form an
essential protein complex that recognizes the 30 splice site during the initialstages of pre-mRNA splicing. A ~100 amino acid domain of SF1 located be-
tween an N-terminal region that is necessary and sufficient U2AF65-interac-
tions, and a C-terminal RNA-binding domain. Despite high sequence conserva-
tion from yeast to mammals, the structure and function of this SF1 ‘mystery’
domain is currently unknown. Here, we demonstrate that the SF1 ‘mystery’
domain participates in the SF1 / U2AF65 interface by comparing heat capacity
changes and chemical shift differences for U2AF65 association with deletion
variants of SF1. Heat capacity changes for association of SF1 with the
U2AF65 interacting domain (UHM) are significantly greater than those
observed for association with a SF1 peptide composed of the minimal
U2AF65-interacting region. In contrast, the heat capacity changes for SF1 pep-
tide/U2AF65UHM association closely matched those predicted from the buried
surface area of the complex. Given that heat capacity changes often correlate
with the amount of surface area buried by complex formation, one possible ex-
planation for this difference was that additional regions of SF1 participate in the
U2AF65UHM interface. To investigate this possibility, the HSQC spectra of
15N-labeled U2AF65-UHM in complex with SF1 C-terminal deletion variants
were compared. Chemical shift differences imply that residues from conserved
‘mystery’ domain of SF1 participate in the U2AF65UHM interface. The influ-
ence of this SF1 domain on affinity and cooperativity of pre-mRNA recognition
by the SF1 / U2AF65 is further investigated by calorimetry and fluorescence an-
isotropy. These studies aid in elucidating the structural and thermodynamic
means for 30 splice site recognition by the essential SF1 and U2AF65 complex.
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We have studied a human delta-opioid receptor interacting with two agonists,
Clozapine and Desmethylclozapine. Delta-opioid receptors belong to the fam-
ily of G protein-coupled receptors, that transduce an intracellular biological sig-
nal upon activation via interaction with a ligand in the transmembrane domain.
Although Clozapine and Desmethylclozapine only differ by a methyl group,
experimental data have evidenced a more efficient action of Desmethylcloza-
pine in the treatment of refractory schizophrenia. A molecular analysis may
help to clarify issues related this difference. Molecular Dynamics simulations
help to elucidate the microscopic mechanism of the interactions between the
ligand and the receptor identifying features barely seen in experiments. How-
ever, as in our case, the time scale of the processes of interest is often too
long to be approached by standard MD techniques. Thus, for our study we
have used a recent technique, the metadynamics, that accelerates MD runs ex-
tending simulation times. Our results pointed out different routes of the drugs
inside the receptor: Clozapine touches a larger number of competing minima
far from the putative receptor active zone than Desmethylclozapine. This latter
spends most of its time inside the receptor close to the residues of the active
zone, inducing noticeable structural modifications. Additionally, the simulation
of the entrance has provided evidence of a stronger interaction with the receptor
of Desmethylclozapine than Clozapine, resulting in a more frequent entrance of
the former. Clozapine exhibits a preferential interaction with the membrane be-
cause of its enhanced hydrophobicity. The free energy surfaces extracted from
the simulations have been used for kinetic Monte Carlo simulations to obtain
reliable residence times of the drugs inside the receptor. The whole results helps
to understand how microscopic details can remarkably affect efficiency and
activity of compounds, supporting the idea of a bottom-up strategy in the
drug design.
3093-Pos Board B140
Understanding the Mechanism of the Anti-angiogenic Activity of Suramin
Karuppanan M. Kathir, Khalil Ibrahim, Thallapuranam
Krishnaswamy Suresh Kumar.
University of Arkansas, Fayetteville, AR, USA.
Angiogenesis is a cellular process that involves the sprouting of new blood ves-
sels from pre-existing ones. Fibroblast growth factors (FGFs) play a crucial role
in the regulation for angiogenesis and tumor metastases. Therefore, intensive
research efforts are on to develop drugs that can specifically inhibit FGF-
induced angiogenesis. FGFs exhibit their cell proliferation activity by binding
to the extracellular D2 domain of their cell surface receptor. Suramin has been
previously shown to inhibit FGF-induced tumors. In this context, in the present
study, we investigate the interaction of suramin with the extracellular D2 do-
main of the FGF receptor (FGFR). Results of the isothermal titration calorim-
etry (ITC) experiments suggest that suramin binds to the D2 domain of FGFR
with a reasonably high affinity (Kd ~ 10
6 M). ITC experiments, carried out at
various salt concentrations, show that suramin-D2 domain interaction is mostly
stabilized by ionic interactions. Limited trypsin digestion experiments and
ANS binding experiments reveal conformational changes in the D2 domain
